Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:October 11, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:October 11, 2019Completed
Condition(s):Multiple Myeloma; Refractory Multiple MyelomaLast Updated:January 5, 2023Withdrawn
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:November 6, 2013Completed
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:September 13, 2023Completed
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:April 4, 2014Completed
Condition(s):Multiple MyelomaLast Updated:March 6, 2015Completed
Condition(s):Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:January 12, 2015Terminated
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:September 21, 2010Completed
Condition(s):Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:December 12, 2017Completed
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:April 18, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.